Loading
Latest filing published 06 Oct 2009 for Monogram Biosciences, Inc., €5.2M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Kenneth F. Siebel discloses dealings in Monogram Biosciences, Inc. to SEC (Form 4). Between 30 September 2008 and 5 August 2009, the trades on record add up to 49 filings.
The open-market side counts 33 purchases for €2.8M alongside 13 sales for €948k. Purchases outweigh sales by €1.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2009: 3 purchases and 4 sales on the market.
In size, the median ticket on the buying side is €24k.
On 6 October 2009 came the latest disclosure, a transaction for €5.2M in Monogram Biosciences, Inc. The last insider purchase was made public on 2 January 2009, 6,504 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 48 declarations